A randomized clinical trial in healthy adults found that co-administered CBD altered THC pharmacokinetics and pharmacodynamics in a dose-dependent manner, providing controlled data on how the two cannabinoids interact when taken orally.
Clinical pharmacologists, medical cannabis prescribers, product formulators, and researchers studying cannabinoid interactions.
CBD dose-dependently modified THC pharmacokinetics and pharmacodynamics
What the researchers found
CBD co-administration modified THC blood levels and subjective effects in a dose-dependent pattern. The pharmacokinetic and pharmacodynamic interactions between oral THC and CBD varied depending on the ratio of the two cannabinoids.
Why it matters
CBD is widely believed to counteract THC effects, but controlled clinical data has been limited. This trial provides rigorous pharmacological evidence on how the two most prominent cannabinoids interact in humans.
The numbers in context
Multiple oral cannabis extract formulations with varying THC:CBD ratios tested. Blood THC levels and subjective effects measured. Dose-dependent CBD modulation of THC observed.
How the study worked
Randomized clinical trial in healthy adults. Compared pharmacokinetics and pharmacodynamics of orally administered cannabis extracts varying in THC and CBD concentrations. Measured blood levels and subjective effects.
What this study cannot tell us
Healthy adult volunteers may not reflect patients with medical conditions. Oral administration only (inhaled routes may produce different interactions). Acute dosing study does not capture chronic use dynamics. Specific extract formulations may not represent all commercial products.
How to read the evidence
Randomized clinical trial with pharmacokinetic and pharmacodynamic endpoints. Rigorous design for a drug interaction study.
When this study was published
Published 2023.
The bigger picture
The THC-CBD interaction is central to cannabis product design and medical cannabis prescribing. Rigorous pharmacokinetic data helps move from anecdotal "entourage effect" claims to evidence-based formulation decisions.
Questions still open
- Does the THC-CBD interaction differ with chronic use? Would different delivery routes (inhaled, sublingual) show the same pharmacokinetic patterns?
Common questions
Does CBD reduce the effects of THC?
Why does the THC:CBD ratio matter?
Read the original research
Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.
JAMA network open, 6(2), e2254752
Citation
Zamarripa, C Austin; Spindle, Tory R; Surujunarain, Renuka; Weerts, Elise M; Bansal, Sumit; Unadkat, Jashvant D; Paine, Mary F; Vandrey, Ryan. (2023). Assessment of Orally Administered Δ9-Tetrahydrocannabinol When Coadministered With Cannabidiol on Δ9-Tetrahydrocannabinol Pharmacokinetics and Pharmacodynamics in Healthy Adults: A Randomized Clinical Trial.. JAMA network open, 6(2), e2254752. https://doi.org/10.1001/jamanetworkopen.2022.54752
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk